Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/T790M/cis-C797S mutation resistance.
Frontiers in oncology（2024）
Key words
non-small cell lung cancer,growth factor receptor,tyrosine kinase inhibitors,programmed cell death 1 inhibitor,anti-vascular endothelial growth factor therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined